Clinical Trials

Colonic Neoplasms

NCT05291156 2024-02-01

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

173 enrolled

Colorectal Neoplasms

NCT06101394 2024-01-25

RECOGNISE

25 enrolled

Thoracic

Lung Neoplasms

NCT06107114 2023-11-22

CZCNRHNSCC

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00997009 2023-11-14

MITO CERV 2

108 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04034459 2023-11-14

AIO-KRK-0116

109 enrolled

Colorectal Neoplasms

NCT02624128 2023-11-13

V-CHANCE

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06118047 2023-11-07

COSTIC

33 enrolled

Colorectal Neoplasms

NCT06081582 2023-10-13

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04262635 2023-08-02

C-CLASSIC

80 enrolled

Colorectal Neoplasms

NCT04189055 2023-06-12

CETIDYL

72 enrolled

Colonic Neoplasms

NCT05160896 2023-06-08

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

90 enrolled

Advanced Metastatic Colorectal Cancer

NCT05745857 2023-02-27

SLURP

25 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT04359199 2023-02-10

QUASAR

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT01855451 2022-11-18

HPVOropharynx

189 enrolled

Tumor-Agnostic

Carcinoma

NCT05155124 2022-09-13

Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC

Phase 1 Unknown

6 enrolled

Colonic Neoplasms

NCT05019534 2022-05-19

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

Phase 1 Unknown

12 enrolled

BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

NCT05103020 2021-11-02

Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases

100 enrolled

Colorectal Neoplasms

NCT04241731 2021-08-30

A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer

Colorectal Neoplasms

NCT03727763 2021-08-19

Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)

30 enrolled

Colorectal Neoplasms

NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Phase 2/3 Unknown

200 enrolled

Colorectal Neoplasms

NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

160 enrolled

Liver Metastasis Colon Cancer

NCT04833036 2021-04-06

c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

120 enrolled

Colorectal Neoplasms

NCT02054442 2021-03-12

COMMENCE

Phase 1/2 Unknown

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04668976 2020-12-21

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

100 enrolled

Colorectal Neoplasms, Cholangiocarcinoma

NCT03608046 2020-10-22

AVETUXIRI

59 enrolled

Colonic Neoplasms

NCT04525326 2020-08-25

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

584 enrolled

Colorectal Neoplasms

NCT04509635 2020-08-12

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Colorectal Neoplasms

NCT02123381 2020-03-17

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

100 enrolled

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT01923987 2019-09-20

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

39 enrolled

Rectal Neoplasms

NCT01802645 2019-09-11

CELIM2

91 enrolled

Colorectal Neoplasms

NCT03944252 2019-07-26

CARACAS

54 enrolled

Anus Neoplasms

NCT03923036 2019-04-22

AVOCETTE

2,000 enrolled

Colorectal Cancer Metastatic

NCT02636088 2018-09-21

LERFOX-C

51 enrolled

Esophageal Neoplasms

NCT03666325 2018-09-11

I-Tackle

43 enrolled

Dermatologic

Skin Neoplasms

NCT02507154 2018-08-21

NKEXPHNC

Phase 1/2 Unknown

31 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT03567629 2018-06-26

Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

130 enrolled

mCRC

NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

152 enrolled

Gallbladder Neoplasms

NCT02296203 2018-02-15

CRICKET

27 enrolled

Colorectal Neoplasms

NCT03401957 2018-01-17

The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment

120 enrolled

Colorectal Neoplasms

NCT03126708 2018-01-04

Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

150 enrolled

Esophageal Squamous Cell Carcinoma

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

69 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT02717923 2017-10-23

A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer

Colorectal Neoplasms

NCT00999700 2017-09-05

INTERCEPTOR

282 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02978313 2016-11-30

Cetuximab Monotherapy Maintenance Treatment in mCRC

Phase 2/3 Unknown

500 enrolled

Colorectal Neoplasms

NCT02753140 2016-04-27

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02215720 2016-02-10

TORERO

Phase 1 Unknown

42 enrolled

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT02071069 2015-11-18

Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

54 enrolled

Incurable Colorectal Cancer

NCT02515734 2015-08-05

DEEPER

360 enrolled